Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. (Q48416095)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 August 2012

Language	Label	Description	Also known as
English	Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status.	scientific article published on 10 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Claudio Colonnese

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Maria Camilla Rossi Espagnet

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Andrea Romano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

L F Calabria

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

F Tavanti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

G Minniti

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

V Coppola

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

S Pugliese

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

D Guida

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

G Francione

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

L M Fantozzi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

A Bozzao

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

0 references

publication date

10 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

European Radiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

513-520

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

describes a project that uses

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Molecular genetic markers as predictors of response to chemotherapy in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Clinical relevance of MGMT in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Apparent diffusion coefficient of human brain tumors at MR imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2601-4

21 January 2018

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22875158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of diffusion-weighted imaging in patients with brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22875158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22875158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22875158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-012-2601-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875158%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48416095&oldid=2209445801"